Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer
Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez‐Autet, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 1, pp. 616-632
Open Access | Times Cited: 19

Showing 19 citing articles:

G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
Pharmacological Research (2024) Vol. 208, pp. 107363-107363
Open Access | Times Cited: 17
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum
Sergi Ferré, Laura I. Sarasola, César Quiroz, et al.
Neuropharmacology (2022) Vol. 223, pp. 109329-109329
Open Access | Times Cited: 34
New paradigms in purinergic receptor ligand discovery
Kenneth A. Jacobson, Balaram Pradhan, Zhiwei Wen, et al.
Neuropharmacology (2023) Vol. 230, pp. 109503-109503
Open Access | Times Cited: 17
The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
Somdatta Saha, Javier González‐Maeso
Neuropharmacology (2023) Vol. 230, pp. 109489-109489
Open Access | Times Cited: 15
Adenosine receptor signalling in Alzheimer’s disease
Phuc N. H. Trinh, Jo‐Anne Baltos, Shane D. Hellyer, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 3, pp. 359-381
Open Access | Times Cited: 18
A Single Point Mutation Blocks the Entrance of Ligands to the Cannabinoid CB2 Receptor via the Lipid Bilayer
Nil Casajuana‐Martin, Gemma Navarro, Ángel González, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 22, pp. 5771-5779
Open Access | Times Cited: 9
Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor
China M. Payne, Jo‐Anne Baltos, Monica Langiu, et al.
ChemBioChem (2024)
Open Access | Times Cited: 1
Optical Control of Dopamine D2-like Receptors with Cell-Specific Fast-Relaxing Photoswitches
Belinda E. Hetzler, Prashant Donthamsetti, Zisis Peitsinis, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 34, pp. 18778-18788
Open Access | Times Cited: 3
One-pot synthesis of novel pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines under microwave irradiation in a green solvent
Jia Hui Ng, Anton V. Dolzhenko
Tetrahedron (2023) Vol. 141, pp. 133521-133521
Closed Access | Times Cited: 2
Homodimerization of CB2cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Homodimerization of Cb2 Cannabinoid Receptor Triggered by a Bivalent Ligand Enhances Cellular Signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
(2024)
Open Access
Overview of the role of purinergic signaling and insights into its role in cancer therapy
Francesco Di Virgilio, Valentina Vultaggio-Poma, Mario Tarantini, et al.
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108700-108700
Open Access
Bifunctional Tools to Study Adenosine Receptors
China M. Payne, Jon Kyle Awalt, Lauren T. May, et al.
Topics in medicinal chemistry (2022), pp. 179-221
Closed Access | Times Cited: 2
Chemical biology-based approaches to study adenosine A2A − dopamine D2 receptor heteromers
Karen J. Gregory, Manuela Jörg
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 395-398
Open Access | Times Cited: 1
Once Upon a Time Adenosine and Its Receptors: Historical Survey and Perspectives as Potential Targets for Therapy in Human Diseases
Daniela Catarzi, Flavia Varano, Sara Calenda, et al.
Topics in medicinal chemistry (2023), pp. 1-46
Closed Access
Editorial: purinergic signalling—perspectives from Australia and New Zealand
Ronald Sluyter, Jennie M. E. Cederholm, Srdjan M. Vlajkovic
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 383-384
Open Access
Allosteric Modulators of Adenosine Receptors
Elisabetta Barresi, Chiara Giacomelli, Claudia Martini, et al.
Topics in medicinal chemistry (2022), pp. 223-273
Closed Access
Page 1

Scroll to top